Leuprolide Terminated Phase 4 Trials for Metastatic Hormone Refractory Prostate Cancer Other

IndicationsStatusPurposePhase
TerminatedOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT01933022A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease